Results 181 to 190 of about 4,347,639 (355)

Higher risk of Long COVID among patients with autoimmune rheumatic diseases and immunomodulatory therapy: a retrospective cohort analysis of national US data.

open access: yesArthritis &Rheumatology, Accepted Article.
Background Little is known about the prevalence of and factors associated with Long COVID in patients with autoimmune rheumatic diseases (AIRDs). Methods We conducted a retrospective cohort study using data from the National Clinical Cohort Collaborative (N3C).
Namrata Singh   +11 more
wiley   +1 more source

Human cancer vaccines

open access: yesAdvanced Drug Delivery Reviews, 2006
Man, Stephen, Tabi, Zsuzsanna
openaire   +2 more sources

Single-cell technologies in mRNA cancer vaccines. [PDF]

open access: yesNPJ Vaccines
Ovcharenko EV   +4 more
europepmc   +1 more source

Supplementary Figure S2 from The mRNA-Based Therapeutic Vaccine NTX250 Induces Potent Antitumor Immunity in HPV-Driven Cancers

open access: gold
Meredith L.L. Leong   +23 more
openalex   +1 more source

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani   +4 more
wiley   +1 more source

Orally Administered Plant-Based Cancer Vaccines: Biological Rationale, Current Evidence, and Translational Barriers

open access: gold
Simona Intonti   +4 more
openalex   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló   +5 more
wiley   +1 more source

Design Considerations for Potent DNA-Platform-Based Cancer Vaccines. [PDF]

open access: yesCurr Opin Biomed Eng
Ferrante AM   +4 more
europepmc   +1 more source

Data from The mRNA-Based Therapeutic Vaccine NTX250 Induces Potent Antitumor Immunity in HPV-Driven Cancers

open access: gold
Meredith L.L. Leong   +23 more
openalex   +1 more source

Home - About - Disclaimer - Privacy